{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:15:30Z","timestamp":1788390930961,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases Centers of Excellence for Influenza Research and Response","award":["75N93021C00016"],"award-info":[{"award-number":["75N93021C00016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58084-y","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:46:39Z","timestamp":1781610399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Broadly reactive human monoclonal antibodies targeting influenza a nucleoprotein lack protective activity in vivo"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3314-584X","authenticated-orcid":false,"given":"Walter N.","family":"Harrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Brice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson S.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Brent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Mudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Ellebedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Webby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"58084_CR1","unstructured":"World Health Organization. Burden of disease (2021). https:\/\/www.who.int\/teams\/global-influenza-programme\/surveillance-and-monitoring\/burden-of-disease"},{"key":"58084_CR2","unstructured":"Centers for Disease Control and Prevention. Disease burden of influenza (2021). https:\/\/www.cdc.gov\/flu\/about\/burden\/index.html"},{"key":"58084_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s12276-021-00603-0","volume":"53","author":"WN Harrington","year":"2021","unstructured":"Harrington, W. N., Kackos, C. M. & Webby, R. J. The evolution and future of influenza pandemic preparedness. Exp. Mol. Med. 53, 737\u2013749 (2021).","journal-title":"Exp. Mol. Med."},{"key":"58084_CR4","first-page":"119","volume":"385","author":"NJ Cox","year":"2014","unstructured":"Cox, N. J., Trock, S. C. & Burke, S. A. Influenza pathogenesis and control. Curr. Top. Microbiol. Immunol. 385, 119\u2013136 (2014).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"58084_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/oxfordjournals.bmb.a072031","volume":"41","author":"DM Mitchell","year":"1985","unstructured":"Mitchell, D. M., McMichael, A. J. & Lamb, J. R. The immunology of influenza. Br. Med. Bull. 41, 80\u201385 (1985).","journal-title":"Br. Med. Bull."},{"key":"58084_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","volume":"16","author":"VN Petrova","year":"2018","unstructured":"Petrova, V. N. & Russell, C. A. The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 16, 47\u201360 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"58084_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-65444-2_3","author":"RG Webster","year":"1972","unstructured":"Webster, R. G. On the origin of pandemic influenza viruses. Curr. Top. Microbiol. Immunol. https:\/\/doi.org\/10.1007\/978-3-642-65444-2_3 (1972).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"58084_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/vim.2017.0141","volume":"31","author":"H Kim","year":"2018","unstructured":"Kim, H., Webster, R. G. & Webby, R. J. Influenza virus: Dealing with a drifting and shifting pathogen. Viral Immunol. 31, 174\u2013183 (2018).","journal-title":"Viral Immunol."},{"key":"58084_CR9","first-page":"65","volume":"2","author":"C Scholtissek","year":"1990","unstructured":"Scholtissek, C. Pigs as \u201cmixing vessels\u201d for the creation of new pandemic influenza A viruses. Med. Princ. Pract. 2, 65\u201371 (1990).","journal-title":"Med. Princ. Pract."},{"key":"58084_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/nyas.12462","volume":"1323","author":"RG Webster","year":"2017","unstructured":"Webster, R. G. & Govorkova, E. A. Continuing challenges in influenza. Ann. N. Y. Acad. Sci. 1323, 115\u2013139 (2017).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"58084_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","volume":"218","author":"EJ Erbelding","year":"2018","unstructured":"Erbelding, E. J. et al. A universal influenza vaccine: The strategic plan for the National Institute of Allergy and Infectious Diseases. J. Infect. Dis. 218, 347\u2013354 (2018).","journal-title":"J. Infect. Dis."},{"key":"58084_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1099\/0022-1317-68-2-433","volume":"68","author":"DC Wraith","year":"1987","unstructured":"Wraith, D. C., Vessey, A. E. & Askonas, B. A. Purified influenza virus nucleoprotein protects mice from lethal infection. J. Gen. Virol. 68, 433\u2013440 (1987).","journal-title":"J. Gen. Virol."},{"key":"58084_CR13","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","volume":"23","author":"SL Epstein","year":"2005","unstructured":"Epstein, S. L. et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23, 5404\u20135410 (2005).","journal-title":"Vaccine"},{"key":"58084_CR14","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1099\/jgv.0.000518","volume":"97","author":"Y Fujimoto","year":"2016","unstructured":"Fujimoto, Y. et al. Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection. J. Gen. Virol. 97, 2104\u20132116 (2016).","journal-title":"J. Gen. Virol."},{"key":"58084_CR15","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1128\/JVI.72.7.5648-5653.1998","volume":"72","author":"JB Ulmer","year":"1998","unstructured":"Ulmer, J. B. et al. Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72, 5648\u20135653 (1998).","journal-title":"J. Virol."},{"key":"58084_CR16","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1038\/mt.2010.202","volume":"18","author":"D Zhou","year":"2010","unstructured":"Zhou, D. et al. A universal influenza A vaccine based on adenovirus expressing matrix-2 ectodomain and nucleoprotein protects mice from lethal challenge. Mol. Ther. 18, 2182\u20132188 (2010).","journal-title":"Mol. Ther."},{"key":"58084_CR17","doi-asserted-by":"crossref","unstructured":"Yewdell, J. W., Frank, E. & Gerhard, W. Expression of influenza A virus internal antigens on the surface of infected P815 cells. J. Immunol. 126, 1814\u20131819 (1981).","DOI":"10.4049\/jimmunol.126.5.1814"},{"key":"58084_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF01310622","volume":"115","author":"GF de Boer","year":"1990","unstructured":"de Boer, G. F., Back, W. & Osterhaus, A. D. M. E. An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species. Arch. Virol. 115, 47\u201361 (1990).","journal-title":"Arch. Virol."},{"key":"58084_CR19","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1128\/CVI.00339-13","volume":"20","author":"R Bodewes","year":"2013","unstructured":"Bodewes, R. et al. In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza A virus nucleoprotein. Clin. Vaccine Immunol. 20, 1333\u20131337 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"58084_CR20","doi-asserted-by":"publisher","first-page":"e01569-16","DOI":"10.1128\/mBio.01569-16","volume":"7","author":"L Hanke","year":"2016","unstructured":"Hanke, L. et al. The antiviral mechanism of an influenza A virus nucleoprotein-specific single-domain antibody fragment. MBio 7, e01569-16 (2016).","journal-title":"MBio"},{"key":"58084_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1126\/science.8456302","volume":"259","author":"J Ulmer","year":"1993","unstructured":"Ulmer, J. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745\u20131749 (1993).","journal-title":"Science"},{"key":"58084_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-065X.1997.tb01009.x","volume":"159","author":"W Gerhard","year":"1997","unstructured":"Gerhard, W., Mozdzanowska, K., Furchner, M., Washko, G. & Maiese, K. Role of the B cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 159, 95\u2013103 (1997).","journal-title":"Immunol. Rev."},{"key":"58084_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/pgmj.52.608.332","volume":"52","author":"JL Virelizier","year":"1976","unstructured":"Virelizier, J. L., Oxford, J. S. & Schild, G. C. The role of humoral immunity in host defence against influenza A infection in mice. Postgrad. Med. J. 52, 332 (1976).","journal-title":"Postgrad. Med. J."},{"key":"58084_CR24","first-page":"202","volume":"71","author":"JP Tite","year":"1990","unstructured":"Tite, J. P. et al. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Immunology 71, 202\u2013207 (1990).","journal-title":"Immunology"},{"key":"58084_CR25","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.4049\/jimmunol.162.7.4163","volume":"162","author":"TM Fu","year":"1999","unstructured":"Fu, T. M. et al. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J. Immunol. 162, 4163\u20134170 (1999).","journal-title":"J. Immunol."},{"key":"58084_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/intimm\/12.1.91","volume":"12","author":"SL Epstein","year":"2000","unstructured":"Epstein, S. L. et al. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8+ cytotoxic T lymphocytes. Int. Immunol. 12, 91\u2013101 (2000).","journal-title":"Int. Immunol."},{"key":"58084_CR27","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","volume":"181","author":"DM Carragher","year":"2008","unstructured":"Carragher, D. M., Kaminski, D. A., Moquin, A., Hartson, L. & Randall, T. D. A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. J. Immunol. 181, 4168\u20134176 (2008).","journal-title":"J. Immunol."},{"key":"58084_CR28","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","volume":"186","author":"MW LaMere","year":"2011","unstructured":"LaMere, M. W. et al. Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J. Immunol. 186, 4331\u20134339 (2011).","journal-title":"J. Immunol."},{"key":"58084_CR29","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/infdis\/jiaa226","volume":"222","author":"JS Turner","year":"2020","unstructured":"Turner, J. S. et al. Impaired cellular immune responses during the first week of severe acute influenza infection. J. Infect. Dis. 222, 1235\u20131244 (2020).","journal-title":"J. Infect. Dis."},{"key":"58084_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1084\/jem.20101352","volume":"208","author":"J Wrammert","year":"2011","unstructured":"Wrammert, J. et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208, 181\u2013193 (2011).","journal-title":"J. Exp. Med."},{"key":"58084_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith, K. et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat. Protoc. 4, 372\u2013384 (2009).","journal-title":"Nat. Protoc."},{"key":"58084_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nature06890","volume":"453","author":"J Wrammert","year":"2008","unstructured":"Wrammert, J. et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453, 667\u2013671 (2008).","journal-title":"Nature"},{"key":"58084_CR33","doi-asserted-by":"publisher","first-page":"e00949","DOI":"10.1128\/JVI.00949-18","volume":"92","author":"R Nachbagauer","year":"2018","unstructured":"Nachbagauer, R. et al. Broadly reactive human monoclonal antibodies elicited following pandemic H1N1 influenza virus exposure protect mice against highly pathogenic H5N1 challenge. J. Virol. 92, e00949-e1018 (2018).","journal-title":"J. Virol."},{"key":"58084_CR34","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1099\/vir.0.010660-0","volume":"90","author":"NL Varich","year":"2009","unstructured":"Varich, N. L. et al. Location of antigenic sites recognized by monoclonal antibodies in the influenza A virus nucleoprotein molecule. J. Gen. Virol. 90, 1730\u20131733 (2009).","journal-title":"J. Gen. Virol."},{"key":"58084_CR35","doi-asserted-by":"publisher","first-page":"8607","DOI":"10.1128\/JVI.00159-10","volume":"84","author":"NA Ilyushina","year":"2010","unstructured":"Ilyushina, N. A. et al. Adaptation of pandemic H1N1 influenza viruses in mice. J. Virol. 84, 8607\u20138616 (2010).","journal-title":"J. Virol."},{"key":"58084_CR36","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1093\/infdis\/jiy711","volume":"219","author":"F Krammer","year":"2019","unstructured":"Krammer, F. & Palese, P. Universal influenza virus vaccines that target the conserved hemagglutinin stalk and conserved sites in the head domain. J. Infect. Dis. 219, S62\u2013S67 (2019).","journal-title":"J. Infect. Dis."},{"key":"58084_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4049\/jimmunol.1801054","volume":"202","author":"LD Estrada","year":"2019","unstructured":"Estrada, L. D. & Schultz-Cherry, S. Development of a universal influenza vaccine. J. Immunol. 202, 392\u2013398 (2019).","journal-title":"J. Immunol."},{"key":"58084_CR38","doi-asserted-by":"publisher","first-page":"6800","DOI":"10.1128\/JVI.74.15.6800-6807.2000","volume":"74","author":"JTM Voeten","year":"2000","unstructured":"Voeten, J. T. M. et al. Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J. Virol. 74, 6800\u20136807 (2000).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58084-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:31:23Z","timestamp":1788388283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58084-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58084"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58084-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27561"}}